200 related articles for article (PubMed ID: 26220289)
21. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation.
Schulman LL; Weinberg AD; McGregor C; Galantowicz ME; Suciu-Foca NM; Itescu S
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1833-7. PubMed ID: 9620914
[TBL] [Abstract][Full Text] [Related]
22. Pretransplant Panel Reactive Antibodies and Lung Transplant Outcomes in Children.
Hayes D; Kopp BT; Sheikh SI; Shell RD; Paul GR; McConnell PI; Tobias JD; Tumin D
Thorac Cardiovasc Surg; 2017 Jan; 65(1):36-42. PubMed ID: 27595243
[No Abstract] [Full Text] [Related]
23. Kidneys From Deceased Elderly Donors: Factors Associated With Adverse Outcomes.
Adekoya AO; Halawa A
Exp Clin Transplant; 2016 Feb; 14(1):32-7. PubMed ID: 26862822
[TBL] [Abstract][Full Text] [Related]
24. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
[TBL] [Abstract][Full Text] [Related]
25. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
[TBL] [Abstract][Full Text] [Related]
26. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance.
Smith JD; Hornick PI; Rasmi N; Rose ML; Yacoub MH
Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S212-5. PubMed ID: 9930450
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
28. Effect of human leukocyte antigen mismatching on the outcomes of pediatric kidney transplantation: a systematic review and meta-analysis.
Shi X; Liu R; Xie X; Lv J; Han W; Zhong X; Ding J
Nephrol Dial Transplant; 2017 Nov; 32(11):1939-1948. PubMed ID: 28992320
[TBL] [Abstract][Full Text] [Related]
29. HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.
Peltz M; Edwards LB; Jessen ME; Torres F; Meyer DM
J Heart Lung Transplant; 2011 Apr; 30(4):426-34. PubMed ID: 21145259
[TBL] [Abstract][Full Text] [Related]
30. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
[TBL] [Abstract][Full Text] [Related]
31. HLA compatibility index: does it have a role in patients after heart transplantation?
Bedanova H; Orban M; Ondrasek J; Stepanova R; Nemec P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):5-11. PubMed ID: 23446213
[TBL] [Abstract][Full Text] [Related]
32. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection.
Khaireddin R; Wachtlin J; Hopfenmüller W; Hoffmann F
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1020-8. PubMed ID: 14673570
[TBL] [Abstract][Full Text] [Related]
33. Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients.
Cicciarelli J; Terasaki P
Transplant Proc; 1989 Feb; 21(1 Pt 1):659-60. PubMed ID: 2650213
[No Abstract] [Full Text] [Related]
34. To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression's effect on survival.
Whitson BA; Lehman A; Wehr A; Hayes D; Kirkby S; Pope-Harman A; Kilic A; Higgins RS
Clin Transplant; 2014 Apr; 28(4):450-61. PubMed ID: 24750290
[TBL] [Abstract][Full Text] [Related]
35. Posttransplant major histocompatibility complex class I chain-related gene A antibodies and long-term graft outcomes in a multicenter cohort of 779 kidney transplant recipients.
Lemy A; Andrien M; Lionet A; Labalette M; Noel C; Hiesse C; Delahousse M; Suberbielle-Boissel C; De Meyer M; Latinne D; Mourad M; Delsaut S; Racapé J; Wissing KM; Toungouz M; Abramowicz D
Transplantation; 2012 Jun; 93(12):1258-64. PubMed ID: 22466790
[TBL] [Abstract][Full Text] [Related]
36. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
37. Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients.
Kirkby S; Whitson BA; Wehr AM; Lehman AM; Higgins RS; Hayes D
J Cyst Fibros; 2015 Jan; 14(1):104-10. PubMed ID: 24948447
[TBL] [Abstract][Full Text] [Related]
38. Induction Therapy for Lung Transplantation in COPD: Analysis of the UNOS Registry.
Duffy JS; Tumin D; Pope-Harman A; Whitson BA; Higgins RS; Hayes D
COPD; 2016 Oct; 13(5):647-52. PubMed ID: 26829054
[TBL] [Abstract][Full Text] [Related]
39. Outcomes in pediatric lung transplant recipients receiving adult allografts.
Hayes D; McConnell PI; Galantowicz M; Whitson BA; Tobias JD; Black SM
Ann Thorac Surg; 2015 Apr; 99(4):1184-91. PubMed ID: 25707585
[TBL] [Abstract][Full Text] [Related]
40. Significance of the donor age effect on kidney transplants.
Terasaki PI; Gjertson DW; Cecka JM; Takemoto S; Cho YW
Clin Transplant; 1997 Oct; 11(5 Pt 1):366-72. PubMed ID: 9361925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
